Azim Ladha

Azim Ladha is a seasoned professional in business development within the contract research organization (CRO) industry, currently serving as Senior Director of Business Development at LSK Global PS since July 2020, specializing in both early phase and late phase clinical trials across various therapeutic areas including oncology and CNS. As Senior Vice President of Business Development at Elixiria Biotech Inc, Azim focuses on developing innovative disease-modifying compounds for neuropathic pain while seeking funding and partnerships. With prior leadership roles at Frontage Laboratories, Inc., Biotrial, and Accutest Global, Azim has extensive experience in clinical development and strategic partnerships. Azim holds a Bachelor of Science degree in Molecular Biology from Université de Montréal.